PHK
CLDX icon

Point72 Hong Kong’s Celldex Therapeutics CLDX Stock Holding History

Point72 Hong Kong’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,559
Closed -$107K – 487
2024
Q1 		$107K Buy
+2,559
New +$105K 0.01% 425
2022
Q2 		– Sell
-1,394
Closed -$47K – 1972
2022
Q1 		$47K Buy
1,394
+511
+58% +$16.3K ﹤0.01% 1347
2021
Q4 		$34K Sell
883
-2,337
-73% -$102K ﹤0.01% 1431
2021
Q3 		$174K Buy
+3,220
New +$151K 0.01% 1206
2018
Q3 		– Sell
-812
Closed -$6K – 929
2018
Q2 		$6K Buy
812
+776
+2,156% +$10.4K ﹤0.01% 692
2018
Q1 		$1K Buy
+36
New +$1.4K ﹤0.01% 822
2017
Q4 		– Sell
-36
Closed -$2K – 875
2017
Q3 		$2K Buy
+36
New +$1.35K ﹤0.01% 641
2017
Q1 		– Sell
-36
Closed -$2K – 758
2016
Q4 		$2K Buy
+36
New +$2.05K ﹤0.01% 770

Other funds holding CLDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return